M. E. Griffith

Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapy.

T. Pawlik, R. Wahl, J. Leal, 2014, International journal of radiation oncology, biology, physics.

Phase 2 Multi-institutional Trial Evaluating Gemcitabine and Stereotactic Body Radiotherapy for Patients With Locally Advanced Unresectable Pancreatic Adenocarcinoma

Albert C. Koong, Joseph M. Herman, Christopher L. Wolfgang, 2014, Cancer.

Patient-reported outcomes of a multicenter phase 2 study investigating gemcitabine and stereotactic body radiation therapy in locally advanced pancreatic cancer.

C. Iacobuzio-Donahue, A. Koong, K. Goodman, 2016, Practical Radiation Oncology.

A Phase 2 Multicenter Study to Evaluate Gemcitabine and Fractionated Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Adenocarcinoma

A. Koong, K. Goodman, D. Chang, 2013 .

Reducing the rate of nosocomially transmitted respiratory syncytial virus.

C. F. Masters, T. Perl, Carolyn F. Masters, 1999, American journal of infection control.